Physician profile
Gregory Charak
NPI 1861759185
$4,315.83
in general payments reported to CMS, 2019-2025
6 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $749 · 2023: $3,199 · 2024: $66.95 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $653 · Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $652.86 |
| Food and Beverage | $413.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,968.37 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $172.46 | 2024-2025 | Signia |
| Acera Surgical, INC. | $74.18 | 2025 | Restrata Wound Matrix |
| Thd America, INC. | $60.00 | 2025 | |
| Ethicon US, LLC | $21.16 | 2025 | Enseal |
| Braintree Laboratories, INC. | $19.66 | 2025 | Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Charak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.